Moleculin Biotech, Inc. Stock Analysis & AI Score
Moleculin Biotech, Inc. (MBRX) has an ST Score of 29.1 (C-), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Moleculin Biotech, Inc. (MBRX) has an ST Score of 29.1 (C-), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy.
- Strongest
- GrowthA+
- Weakest
- ProfitabilityF
All factor grades
- GrowthA+
- ValuationC
- Financial StrengthD
- MomentumD
- ProfitabilityF
- Piotroski1/9
Contact
MBRX stock: frequently asked questions
What is MBRX's ST Score?
Moleculin Biotech, Inc. (MBRX) has an ST Score of 29.1 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MBRX a buy, hold, or sell?
Analysts rate MBRX a Buy. Our ST Score grades it C- (29.1/100). The ST Score is a data-driven signal, not a recommendation.
What are MBRX's factor grades?
Valuation C, Profitability F, Financial Strength D, Momentum D, Growth A+.
What is MBRX's valuation grade?
Moleculin Biotech, Inc. (MBRX) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MBRX's growth grade?
Moleculin Biotech, Inc. (MBRX) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MBRX's profitability grade?
Moleculin Biotech, Inc. (MBRX) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MBRX's financial strength grade?
Moleculin Biotech, Inc. (MBRX) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is MBRX's Piotroski score?
Moleculin Biotech, Inc. (MBRX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.